rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPHAR Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10 Mar ' 09
Sources of funds
Owner's fund
Equity share capital 18.66 18.38 17.48 15.98 15.98
Share application money 3.13 5.87 2.74 - -
Preference share capital - - - - -
Reserves & surplus 45.66 39.64 33.97 25.02 22.54
Loan funds
Secured loans 91.92 80.65 51.05 29.76 22.70
Unsecured loans - - - 0.04 1.21
Total 159.36 144.54 105.24 70.80 62.43
Uses of funds
Fixed assets
Gross block 78.83 81.64 40.84 37.32 37.16
Less : revaluation reserve - - - - -
Less : accumulated depreciation 12.43 11.82 7.46 5.19 3.45
Net block 66.40 69.82 33.38 32.13 33.70
Capital work-in-progress - - 13.66 6.39 3.19
Investments 1.43 1.43 - - -
Net current assets
Current assets, loans & advances 175.11 136.11 87.57 44.10 38.91
Less : current liabilities & provisions 83.58 62.82 30.39 13.33 15.40
Total net current assets 91.53 73.29 57.19 30.77 23.50
Miscellaneous expenses not written - - 1.01 1.51 2.03
Total 159.36 144.54 105.24 70.80 62.43
Notes:
Book value of unquoted investments 1.43 1.43 - - -
Market value of quoted investments - - - - -
Contingent liabilities 14.07 - - - -
Number of equity sharesoutstanding (Lacs) 186.56 183.81 174.81 159.81 159.81
Close
Add Bafna Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bafna Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close